Literature DB >> 25596303

Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.

Augusto M Carvalho1, Juqueline R Cristal1, Aline C Muniz2, Lucas P Carvalho3, Regis Gomes1, José C Miranda1, Aldina Barral4, Edgar M Carvalho3, Camila I de Oliveira4.   

Abstract

BACKGROUND: Leishmaniasis is caused by parasites transmitted to the vertebrate host by infected sand flies. During transmission, the vertebrate host is also inoculated with sand fly saliva, which exerts powerful immunomodulatory effects on the host's immune response.
METHODS: We conducted a prospective cohort analysis to characterize the human immune response to Lutzomyia intermedia saliva in 264 individuals, from an area for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.
RESULTS: Antibodies were found in 150 individuals (56.8%); immunoglobulin G1 and G4 were the predominant subclasses. Recall responses to salivary gland sonicate showed elevated production of interleukin 10 (IL-10), interleukin 13, interferon γ, CXCL9, and CCL2 compared with controls. CD4(+)CD25(+) T cells, including Foxp3(+) cells, were the main source of IL-10. L. braziliensis replication was increased (P < .05) in macrophages cocultured with saliva-stimulated lymphocytes from exposed individuals and addition of anti-IL-10 reverted this effect. Positive correlation between antibody response to saliva and cellular response to Leishmania was not found. Importantly, individuals seropositive to saliva are 2.1 times more likely to develop CL (relative risk, 2.1; 95% confidence interval, 1.07-4.2; P < .05).
CONCLUSIONS: Exposure to L. intermedia sand flies skews the human immune response, facilitating L. braziliensis survival in vitro, and increases the risk of developing CL.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ELISA; L. braziliensis; chemokines; cutaneous leishmaniasis; cytokines; killing assay; lutzomyia intermedia; sand fly saliva

Mesh:

Substances:

Year:  2015        PMID: 25596303      PMCID: PMC4539914          DOI: 10.1093/infdis/jiv020

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms.

Authors:  G Haskó; D G Kuhel; J F Chen; M A Schwarzschild; E A Deitch; J G Mabley; A Marton; C Szabó
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

2.  T regulatory-1 cells induce IgG4 production by B cells: role of IL-10.

Authors:  Judith S Satoguina; Esther Weyand; John Larbi; Achim Hoerauf
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

3.  Nocturnal activity rhythms of Lutzomyia intermedia and Lutzomyia whitmani (Diptera: Psychodidae) in a transmission area of American cutaneous leishmaniasis in Rio de Janeiro State, Brazil.

Authors:  Nataly A Souza; Cláudia A Andrade-Coelho; Alexandre A Peixoto; Elizabeth F Rangel
Journal:  J Med Entomol       Date:  2005-11       Impact factor: 2.278

4.  Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.

Authors:  G Haskó; C Szabó; Z H Németh; V Kvetan; S M Pastores; E S Vizi
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

5.  Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity.

Authors:  Regis B Gomes; Cláudia Brodskyn; Camila I de Oliveira; Jackson Costa; José C Miranda; Arlene Caldas; Jesus G Valenzuela; Manoel Barral-Netto; Aldina Barral
Journal:  J Infect Dis       Date:  2002-10-16       Impact factor: 5.226

6.  Detection of species-specific antibody response of humans and mice bitten by sand flies.

Authors:  I Rohousova; S Ozensoy; Y Ozbel; P Volf
Journal:  Parasitology       Date:  2005-05       Impact factor: 3.234

7.  Clinical characteristics of human Leishmania braziliensis braziliensis infections.

Authors:  E A Llanos Cuentas; C C Cuba; A C Barreto; P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

8.  Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen.

Authors:  Dorlene M C Aquino; Arlene J M Caldas; José Carlos Miranda; Antonio A M Silva; Manoel Barral-Netto; Aldina Barral
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

9.  Adenosine, AMP, and protein phosphatase activity in sandfly saliva.

Authors:  O Katz; J N Waitumbi; R Zer; A Warburg
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

10.  Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America.

Authors:  Clarissa Teixeira; Regis Gomes; Nicolas Collin; David Reynoso; Ryan Jochim; Fabiano Oliveira; Amy Seitz; Dia-Eldin Elnaiem; Arlene Caldas; Ana Paula de Souza; Cláudia I Brodskyn; Camila Indiani de Oliveira; Ivete Mendonca; Carlos H N Costa; Petr Volf; Aldina Barral; Shaden Kamhawi; Jesus G Valenzuela
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23
View more
  12 in total

1.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

2.  Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis.

Authors:  Aymen Tlili; Soumaya Marzouki; Emna Chabaane; Maha Abdeladhim; Wafa Kammoun-Rebai; Rahma Sakkouhi; Nabil Belhadj Hmida; Fabiano Oliveira; Shaden Kamhawi; Hechmi Louzir; Jesus G Valenzuela; Mélika Ben Ahmed
Journal:  J Invest Dermatol       Date:  2017-10-17       Impact factor: 8.551

3.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

4.  Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.

Authors:  Regis Gomes; Katrine Cavalcanti; Clarissa Teixeira; Augusto M Carvalho; Paulo S Mattos; Juqueline R Cristal; Aline C Muniz; José Carlos Miranda; Camila I de Oliveira; Aldina Barral
Journal:  PLoS Negl Trop Dis       Date:  2016-11-03

Review 5.  Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and Leishmania.

Authors:  Tereza Lestinova; Iva Rohousova; Michal Sima; Camila I de Oliveira; Petr Volf
Journal:  PLoS Negl Trop Dis       Date:  2017-07-13

6.  Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasis.

Authors:  Augusto M Carvalho; Kiyoshi F Fukutani; Rohit Sharma; Rebecca P Curvelo; José Carlos Miranda; Aldina Barral; Edgar M Carvalho; Jesus G Valenzuela; Fabiano Oliveira; Camila I de Oliveira
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

7.  Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis.

Authors:  Esther Garde; Laura Ramírez; Laura Corvo; José C Solana; M Elena Martín; Víctor M González; Carlos Gómez-Nieto; Aldina Barral; Manoel Barral-Netto; José M Requena; Salvador Iborra; Manuel Soto
Journal:  Front Cell Infect Microbiol       Date:  2018-04-05       Impact factor: 5.293

Review 8.  Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America.

Authors:  Claudia I Brodskyn; Shaden Kamhawi
Journal:  Front Cell Infect Microbiol       Date:  2018-07-26       Impact factor: 5.293

9.  Interventions for American cutaneous and mucocutaneous leishmaniasis.

Authors:  Mariona Pinart; José-Ramón Rueda; Gustavo As Romero; Carlos Eduardo Pinzón-Flórez; Karime Osorio-Arango; Ana Nilce Silveira Maia-Elkhoury; Ludovic Reveiz; Vanessa M Elias; John A Tweed
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27

10.  Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.

Authors:  Wafa Kammoun-Rebai; Narges Bahi-Jaber; Ikbel Naouar; Amine Toumi; Afif Ben Salah; Hechmi Louzir; Amel Meddeb-Garnaoui
Journal:  PLoS Negl Trop Dis       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.